Articles On ImpediMed (ASX:IPD)

Title Source Codes Date
Trading Places: Which recent ASX IPO saw investees top up their holdings on market?

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Stockhead IPD 1 week ago
5 medical stocks to watch out for in 2022 -TLX, RHT, CYC, IPD, AVR 

Highlights The rising population and the rise in health issues are increasing the demand for healthcare products and services. People’s lifestyle is one of the reasons for rising health issues in the present times. TLX, RHT, CYC, IPD,...

Kalkine Media IPD 2 weeks ago
ImpediMed (ASX:IPD) completes share purchase plan heavily oversubscribed

ImpediMed (IPD) completes its share purchase plan, heavily oversubscribed by more than $27 million The share purchase plan (SPP) closed on November 12 and saw applications totalling over $32 million – well in excess of the company’s target...

themarketherald.com.au IPD 3 weeks ago
ScoPo’s Powerplays: Investors become a ‘little more picky’ as markets continue to push ever higher

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Stockhead IPD 1 month ago
These were the best performing ASX healthcare shares in October

It was a mixed bag of results for ASX healthcare shares as we walked through October, as some names came in red hot, whilst others missed the mark completely. After a sharp downturn in late September, where it lost around 7% in just one w...

Motley Fool IPD 1 month ago
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week With a slew o...

Stockhead IPD 1 month ago
Impedimed (ASX:IPD) share price dips following capital raising update

The Impedimed Limited (ASX: IPD) share price has come out of a trading halt today to backtrack mid-afternoon. This comes after the medical technology company provided an update on its recent equity raise. At the time of writing, Impedimed...

Motley Fool IPD 1 month ago
Closing Bell: Tech and Crown shares lead ASX to another day in the green

The ASX finished in the green by just 0.03%. Today’s gain was spurred by a 1.34% rally in tech shares as well as a rally in Crown (ASX:CWN) shares in the wash-up of the Victorian government’s royal commission. Despite the report finding the...

Stockhead IPD 1 month ago
What’s going on with the Impedimed (ASX:IPD) share price?

Market watchers interested in the Impedimed Limited (ASX: IPD) share price have woken to another frosty session as the company’s stock remains frozen for a second day. Impedimed’s shares were halted from trade yesterday while the company u...

Motley Fool IPD 1 month ago
Closing Bell: ASX continues its positive run in October, up 3.6pc in 3 weeks

The ASX is off to a positive start this week, putting its total gains over the past three weeks up to about 3.6%. The ASX 200 closed 0.34% higher – at 7,441 points. Spurring today’s gains was energy with a 2.64% gain while resources and uti...

Stockhead IPD 1 month ago
Canaccord, Wilsons on board for ImpediMed raise

ImpediMed is launching a capital raise on Monday morning, on the back of positive clinical trial results last week.

AFR IPD 1 month ago
ScoPo’s Powerplays: Reopening brings previously neglected health stocks into play

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Power says...

Stockhead IPD 1 month ago
Closing Bell: ASX shrugs it off with another day of gains as investors clamour for more IPOs

As the world emerges from the pandemic, markets are now contending with an energy crisis, a global shipping glut and the prospect of central banks starting to raise interest rates. But so far this week, investors are shrugging it all off as...

Stockhead IPD 1 month ago
Closing Bell: ASX fails to maintain gains, despite tech gaining 1.7pc

Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil...

Stockhead IPD 1 month ago
The Impedimed (ASX:IPD) share price is up 10% on trial success

The Impedimed Limited (ASX: IPD) share price is making good ground today, having climbed 10% from the market open to now trade at 16.5 cents. Impedimed shares are again on the move after coming out of a trading halt that was requested bef...

Motley Fool IPD 1 month ago
ImpediMed (ASX:IPD) completes lymphoedema prevention trial

ImpediMed (IPD) has rounded off its PREVENT trial, successfully meeting its primary end point in the largest recorded trial to assess lymphoedema prevention The findings were based on a 1,200-person trial over six and a half years, spannin...

themarketherald.com.au IPD 1 month ago
ScoPo’s Powerplays: ‘Market volatility could lead to a rally by Christmas’

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Stockhead IPD 2 months ago
Market Highlights and 5 ASX Small Caps to watch on Thursday

Wall Street mixed as ‘debt ceiling’ deadline approaches US stock markets finished in mixed territories on Thursday, as a last session selloff turned the Nasdaq from positive to negative at the close. The Dow Jones rose by 0.26%, the S&P...

Stockhead IPD 2 months ago
Why the Impedimed (ASX:IPD) share price is rocketing 9% today

The Impedimed Limited (ASX: IPD) share price is on the move during mid-afternoon trade. This comes as the medical technology company announced a positive update in regards to its SOZO Heart Failure Program. At the time of writing, Impedime...

Motley Fool IPD 2 months ago
Market Highlights and 5 ASX Small Caps to watch on Monday

Wall Street mixed to end a volatile week The three US stock marker benchmarks finished the week in mixed territories on Friday, after a volatile week of trading. The Dow Jones rose by 0.1%, S&P 500 by 0.15%, but the tech heavy Nasdaq sl...

Stockhead IPD 2 months ago
Market Highlights and 5 ASX Small Caps to watch on Monday

Wall Street falls again for fourth consecutive day All three major US stock market benchmarks fell on Friday for the fourth consecutive day. Equity investors are concerned about the rising Delta variant cases, and the impending Fed tapering...

Stockhead IPD 2 months ago
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Stockhead IPD 3 months ago
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead IPD 3 months ago
FNArena Corporate Results Monitor – 26-08-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow Formwork and Construction Services ((ABC)) - AdBri ((APT)) - Afterpay ((APA)) - APA Group ((AMI)) - Aurelia Metals ((AOF)) - Australian Unity Office Fund (...

FNArena IPD 3 months ago
Best calls to action – Thursday, 26 August

Today, Thursday the 26th of August, we are happy to buy Lovisa (ASX:LOV), Zip Co Ltd (ASX:Z1P), Oil Search Ltd (ASX:OSH), Idp Education Ltd (ASX:IEL), Dalrymple Bay (ASX:DBI), Universal Store (ASX:UNI), Acrow Formwork (ASX:ACF), Wagners Hld...

Morgans IPD 3 months ago
Impedimed (ASX:IPD) share price rises with 46% lift in revenues

The Impedimed Limited (ASX: IPD) share price is appreciating after the company released its full-year results for FY21. At the time of writing, shares in the healthcare company are trading for 13 cents each – up 4%. For context, the ASX Al...

Motley Fool IPD 3 months ago
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

Stockhead IPD 3 months ago
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough

IDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with the Australian Government to potentially assist with the production of a COVID-19 vaccine. There was recent media interest surrounding a mR...

Stockhead IPD 3 months ago
Market Highlights and 5 ASX Small Caps to watch on Monday

Wall Street rose ahead of world centrals banks meeting this week All three US stock market indexes bounced back on Friday, ahead of this week’s Jackson Hole Economic Policy Symposium, a virtual meeting of world central banks leaders held be...

Stockhead IPD 3 months ago
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead IPD 3 months ago
ScoPo’s Powerplays: Solid earnings on health stocks all round, but price action stays with larger caps

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead IPD 4 months ago
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead IPD 4 months ago
Technical analysis: 5 July 2021

ImpediMed (IPD), The A2 Milk Company (A2M), Unibail-Rodamco-Westfield (URW), Harvey Norman Holdings (HVN) & IDP Education (IEL).

Morgans IPD 5 months ago
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

Stockhead IPD 5 months ago
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead IPD 6 months ago
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

Stockhead IPD 7 months ago
Closing Bell: ASX 200 near day’s high after RBA upgrades GDP

The market is trading near day’s high at the close, after the Reserve Bank of Australia’s (RBA) maintained status quo in its latest policy announcement and upgraded the country’s GDP growth estimates. The benchmark index ASX 200 was up 35.5...

Kalkine Media IPD 7 months ago
Impedimed (ASX:IPD) share price bounces on ‘significant’ hospital finding

The Impedimed Limited (ASX: IPD) share price is bouncing this morning after the company announced positive progress in its SOZO technology for heart patients.  The Impedimed share price has been seesawing between the opening price of 12 ce...

Motley Fool IPD 7 months ago
ScoPo’s Powerplays: A disappointing week for healthcare investors

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead IPD 7 months ago
The Impedimed (ASX:IPD) share price rocketed 13% today. Here’s why

The Impedimed Limited (ASX: IPD) share price was off to a flying start this morning, up 13% at market open. The positive price movement came as the medical technology company announced it received Food and Drug Administration (FDA) clearan...

Motley Fool IPD 7 months ago
Market highlights and 6 ASX small caps to watch on Thursday

Wall Street bounces back All major indices in the US have bounced back, after falling the previous day. Both the Dow Jones and S&P 500 rose by 0.93%, while tech heavy NASDAQ also rose by 1.19%. It was a broad-based increase across all s...

Stockhead IPD 7 months ago
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The ASX he...

Stockhead IPD 7 months ago
ImpediMed on publication of new SOZO data

ImpediMed (ASX.IPD) has announced the publication of a peer-reviewed manuscript demonstrating the clinical utility of its SOZO device in monitoring heart failure patients.

BiotechDispatch IPD 8 months ago
ScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports near

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The health...

Stockhead IPD 8 months ago
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week “Another s...

Stockhead IPD 8 months ago
Why the Impedimed (ASX:IPD) share price shot higher this morning

The Impedimed Ltd (ASX: IPD) share price shot higher this morning, up 5% in morning trade.  This came after the ASX medical technology company reported a significant uptick in the number of tests conducted with one of its leading medical d...

Motley Fool IPD 9 months ago
FNArena Corporate Results Monitor – 23-02-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((3PL)) - 3P Learning ((ALD)) - Ampol ((AD8)) - Audinate Group ((BIN)) - Bingo Industries ((BSL)) - BlueScope Steel ((BKG)) - Booktopia Group ((CNU)) - Chorus ((CGC)) - Co...

FNArena IPD 9 months ago
Why the Impedimed (ASX:IPD) share price will be on watch today

The Impedimed Limited (ASX: IPD) share price will be closely watched by investors this morning. This comes after the medical technology company announced that it has concluded its long-running Prevent trial. At the closing bell yesterday,...

Motley Fool IPD 10 months ago
ImpediMed (ASX:IPD) Edges Up on ASX on Acquiring HITRUST Certification

Summary ImpediMed Limited (ASX:IPD) has secured the Health Information Trust Alliance Certification (HITRUST). HITRUST sets the global standard for safeguarding information. ImpediMed’s goal is to make continuous improvements in safeg...

Kalkine Media IPD 11 months ago
Walk Through ImpediMed’s (ASX:IPD) Sophisticated Medical Product- SOZO®

Summary ImpediMed Limited (ASX:IPD) is an emerging contemporary medical technology company that produces a family of FDA cleared and CE Marked medical devices. The Company uses bioimpedance spectroscopy (BIS) technologies to generate p...

Kalkine Media IPD 11 months ago